Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


AMA Announces New Online Education to Help Physicians Use and Interpret Cancer Panel Testing in Practice


 

As part of its program aimed at educating physicians and other health care professionals on the benefits and limitations of genomics and precision medicine, the American Medical Association (AMA) today announced two new online educational modules focused on somatic cancer panel testing. The modules will help physicians determine when cancer panel testing is appropriate for their patients and how to interpret the test results to inform the best treatment options for patients.

"We know that genetic technology is rapidly expanding, often too quickly for physicians and other health professionals to become familiar with new technologies before they become clinically available. In particular, somatic cancer panel testing is a relatively new and quickly expanding type of test in cancer care," said AMA President David O. Barbe, M.D. "With many physicians who treat and follow cancer patients unfamiliar with the use of these panels, and little clinical guidance yet available for their use, the new modules will help physicians better understand the factors that should be considered when incorporating cancer panel testing into patient care."

The two modules provide physicians and other health professionals with a detailed overview of somatic cancer panel testing, also known as cancer genomic panels or tumor molecular panels, and the resources available to assist them as they consider using it to inform patient care.

The first module explores how cancer panel testing can help physicians identify genetic variants driving cancer growth and the targeted therapies that can expand their patients' treatment options. This module details the types of clinical information that can be gleaned from large somatic cancer panels as well as how to determine which patients are ideal candidates for testing. The second module, launched today, focuses on helping providers interpret results of somatic cancer panel testing, as well as how to identify key information within the reports that is important for patient care.

Both of these modules are part of the 12-module online "Precision Medicine for Your Practice" series, being developed by the AMA, Scripps Translational Science Institute, and The Jackson Laboratory. Each module in the series is freely available, carries CME credit, and presents interactive case studies for clinicians to practice what they've learned--applying genetic information to patient cases, assessing the utility of genetic information, and learning about benefits and limitations of new genetic tests.

Previous modules have addressed expanded carrier screening and prenatal cell-free DNA screening. Upcoming modules will focus on other applications of genetic testing, including genomic sequencing in the healthy individual, cardiogenomics, neurogenomics, and pharmacogenomics. All future and previously released modules will be available online at the AMA Education Center.

This effort furthers the AMA's work over the last decade to ensure that physicians have access to the resources and support they need to appropriately integrate personalized medicine services into practice to precisely target treatment and improve health outcomes. The AMA will continue to focus efforts on improving the health of the nation and support efforts that ensure patients live richer and fuller lives while reducing health care costs.

 
Share:

Related Articles:


Recent Articles

Trump Picks Supreme Court Nominee

President Donald Trump announced his pick to replace Justice Kennedy on Monday evening, July 9. He selected 53-year-old Judge Brett Kavanaugh to serve on the Supreme Court, pending Congressional approval.

Read More

Before Stage Four

Providers wouldn't wait to intervene with breast cancer until it had become metastatic. Yet, delayed reaction is too often the case when it comes to suicide prevention efforts.

Read More

Nashville Fosters Innovation at Startup Day Event

The Department of Health and Human Services (HHS) is looking to invest in innovative healthcare startups, according to an official who attended the Startup Day Nashville in June.

Read More

MHAMT Leader Takes on National Role

MHA of Middle Tennessee leader Tom Starling was inducted as board chair of the national Mental Health America organization at last month's annual meeting.

Read More

The Opioid Crisis - Where Do We Go From Here?

As discussed in last month's edition of the Nashville Medical News, the Tennessee General Assembly recently approved a significant portion of Governor Bill Haslam's "TN Together" plan to combat the opioid crisis in Tennessee.

Read More

The Opioid Crisis - Where Do We Go From Here?

As discussed in last month's edition of the Nashville Medical News, the Tennessee General Assembly recently approved a significant portion of Governor Bill Haslam's "TN Together" plan to combat the opioid crisis in Tennessee.

Read More

Op-Ed: The Need for Effective Measures to Treat Mental Illness

There is an urgent need for more dynamic and effective measures to care for the growing number of Americans with serious mental illness - in Middle Tennessee and across the nation.

Read More

Behavioral Health Rounds

Read More

SAFE Clinic Opens to Victims of Sexual Violence

Nashville's first freestanding SAFE Clinic is a dedicated, healing environment for rape victims.

Read More

AAC Utilizing AI to Improve Outcomes

Artificial intelligence helping staff, patients at AAC

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: